| Absorption |
| Blood-Brain Barrier | BBB- | 0.7626 |
| Human Intestinal Absorption | HIA- | 0.8219 |
| Caco-2 Permeability | Caco2- | 0.6193 |
| P-glycoprotein Substrate | Substrate | 0.5863 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8917 |
| Non-inhibitor | 0.9283 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8284 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6359 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8533 |
| CYP450 2D6 Substrate | Non-substrate | 0.8352 |
| CYP450 3A4 Substrate | Non-substrate | 0.8003 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9245 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9194 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9364 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9236 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9000 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9867 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7586 |
| Non-inhibitor | 0.9068 |
| AMES Toxicity | Non AMES toxic | 0.8866 |
| Carcinogens | Non-carcinogens | 0.7684 |
| Fish Toxicity | Low FHMT | 0.5734 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9303 |
| Honey Bee Toxicity | Low HBT | 0.7382 |
| Biodegradation | Not ready biodegradable | 0.6597 |
| Acute Oral Toxicity | III | 0.7655 |
| Carcinogenicity (Three-class) | Non-required | 0.7341 |